Press Room

News / Jul 11, 2019

Concert at Jerónimos Monastery

Celebrating our 60th Anniversary

60th Anniversary Concert | Hovione

 

On July 9th 2019, Hovione offered a two piano concert at Jerónimos Monastery in Lisbon, to celebrate our 60th anniversary.

A beautiful moment where we joined together family, team members, clients, friends and stakeholders that make Hovione a great Company.

 

No dia 9 de julho de 2019 a Hovione ofereceu um concerto para dois pianos no Mosteiro dos Jerónimos para celebrar os 60 anos.

Um momento muito especial que juntou família, colaboradores, clientes, amigos e todos os que ajudam a fazer da Hovione uma grande Empresa.

 

 

60th Anniversary Villax Family| Hovione
Peter, Diane and Guy Villax.
60th Anniversary Villax Family| Hovione
Villax Family.
60th Anniversary | Hovione
60th Anniversary Diane Villax Speech | Hovione
60th Anniversary Diane Villax Speech | Hovione
60th Anniversary Guy Villax Speech | Hovione
60th Anniversary Sofia Villax Speech | Hovione
60th Anniversary Claustros Concert | Hovione
60th Anniversary Piano Concert | Hovione
60th Anniversary Concert| Hovione
60th Anniversary Mario Laginha Concert | Hovione
Mário Laginha
60th Anniversary Concert Pedro Burmester | Hovione
Pedro Burmester
60th Anniversary Claustros Concert | Hovione
60th Anniversary Sofia Villax with Pedro Burmester and Mario Laginha | Hovione
Pedro Burmester, Sofia Villax and Mário Laginha

 

 

60th Anniversary find more button | Hovione

 

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025